CYP3A4 Polymorphism and Lopinavir Toxicity in an HIV-Infected Pregnant Woman.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 1, p. 61, doi. 10.1007/s40261-014-0245-7
- By:
- Publication type:
- Article
Works matching IS 11732563 AND DT 2015 AND VI 35 AND IP 1
Results: 7
1
2
Pharmacokinetic Properties of Two Erlotinib 150 mg Formulations with a Genetic Effect Evaluation in Healthy Korean Subjects.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 1, p. 31, doi. 10.1007/s40261-014-0248-4
- By:
- Publication type:
- Article
3
Indirect Comparison Between Subcutaneous Biologic Agents in Ankylosing Spondylitis.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 1, p. 23, doi. 10.1007/s40261-014-0246-6
- By:
- Publication type:
- Article
4
Remifentanil, Fentanyl, or the Combination in Surgical Procedures in the United States: Predictors of Use in Patients with Organ Impairment or Obesity.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 1, p. 53, doi. 10.1007/s40261-014-0251-9
- By:
- Publication type:
- Article
5
Effect of Concomitant Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on the Pharmacokinetics of Atorvastatin.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 1, p. 45, doi. 10.1007/s40261-014-0252-8
- By:
- Publication type:
- Article
6
Quality of Life and Healthcare Resource in Patients Receiving Opioids for Chronic Pain: A Review of the Place of Oxycodone/Naloxone.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 1, p. 1, doi. 10.1007/s40261-014-0254-6
- By:
- Publication type:
- Article
7
Pharmacokinetics of Hydrocodone Extended-Release Tablets Formulated with Different Levels of Coating to Achieve Abuse Deterrence Compared with a Hydrocodone Immediate-Release/Acetaminophen Tablet in Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2015, v. 35, n. 1, p. 13, doi. 10.1007/s40261-014-0244-8
- By:
- Publication type:
- Article